Home dialysis firm snaps up £9m
This article was originally published in Clinica
Quanta Fluid Solutions, an Alcester, UK firm developing a home haemodialysis system, has raised £9m in its first equity financing round. NBGI Ventures, Seroba Kernal and Wellington Partners were co-lead investors, with BrainsToVentures, a private investor network, also contributing. Quanta's SelfCare+ is a portable, table-top haemodialysis system designed for use by chronic renal disease patients in their homes. While there are home dialysis systems already on the market, such as NxStage's System One, Quanta's technology represents the next-generation technology that offers improved clinical efficacy and functionality, John Milad, investment manager at NBGI Ventures, told Clinica. "It will help to enhance patient outcomes and reduce overall cost of treatment," he said.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.